Literature DB >> 11025687

Clinical use of cystine supersaturation measurements.

Y Nakagawa1, J R Asplin, D S Goldfarb, J H Parks, F L Coe.   

Abstract

PURPOSE: We measured the concentration and solubility of cystine in urine from patients with cystinuria or calcium stones and from normal subjects to determine whether urine cystine supersaturation can be calculated from a standard nomogram of solubility versus pH or needs to be measured directly. We also evaluated whether increasing pH of the 24-hour collection recovered enough crystallized cystine to increase cystine supersaturation.
MATERIALS AND METHODS: Cystine concentration, pH and usual stone risk factors were measured on 50 ml. aliquots of 24-hour collections from 24 patients with cystinuria, 22 calcium stone formers and 15 normal subjects. After 48 hours of incubation with sodium bicarbonate, a second aliquot was taken from the 24-hour collection for cystine concentration. The original urine at its ambient pH was incubated with an excess of cystine crystals for 24, 48, 72 or 96 hours at 37C to determine solubility and kinetics of equilibration.
RESULTS: Cystine solubility varied so widely at any pH range that no predictive nomogram could be relied on for calculating supersaturation. Addition of sodium bicarbonate to the 24-hour urine significantly increased cystine concentration. Urine from stone formers had higher cystine solubility than urine from normal subjects.
CONCLUSIONS: Clinical management of cystinuria can be improved by direct measurement of cystine solubility because it varies widely at any given pH. Increasing 24-hour collection pH with sodium bicarbonate additionally improves accuracy of supersaturation measurement by recovering crystallized cystine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11025687

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

Review 2.  Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases.

Authors:  Michael H Lee; Amrik Sahota; Michael D Ward; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 3.  Cystinuria: mechanisms and management.

Authors:  Donna J Claes; Elizabeth Jackson
Journal:  Pediatr Nephrol       Date:  2012-01-27       Impact factor: 3.714

Review 4.  Nephrolithiasis.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 5.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

6.  Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children.

Authors:  Ralph J DeBerardinis; Curtis R Coughlin; Paige Kaplan
Journal:  J Urol       Date:  2008-10-31       Impact factor: 7.450

Review 7.  Simplified methods for the evaluation of the risk of forming renal stones and the follow-up of stone-forming propensity during the preventive treatment of stone-formation.

Authors:  Fèlix Grases; Antonia Costa-Bauzá
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 8.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 9.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

10.  Monosodium urate stones are rare, and urine pH is not low in cystinuria.

Authors:  John R Asplin; Kristina Penniston; David S Goldfarb
Journal:  Am J Kidney Dis       Date:  2013-07       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.